Markus Neumann

2.7k citations
48 papers · 2.1k · h-index 25

Impact in

  • Virology top 1%
    • HIV Research and Treatment
    • Antimicrobial Peptides and Activities

Papers in

    • Microbial Metabolic Engineering and Bioproduction 4
    • SARS-CoV-2 and COVID-19 Research 6
    • HIV/AIDS drug development and treatment 5
    • SARS-CoV-2 detection and testing 4
    • COVID-19 Clinical Research Studies 4

Markus Neumann

47 papers receiving 2.1k citations

Peers

Markus Neumann
Comparison fields: 5 of 145
  • Virology 440
  • Microbiology 138
  • Biomaterials 286
  • Nephrology 143
  • Infectious Diseases 311
Replace A. Larry Arsenault with:
A. Larry Arsenault Canada
Christine Péchoux France
Victoria J. Madden United States
António Matos Portugal
Ying Hu China
Yangyang Li China
Thomas Hanke Germany
Michael Super United States
Rudolph Reimer Germany
Abdulhafez Selim Egypt
Markus Neumann relative to A. Larry Arsenault Canada A. Larry Arsenault's profile →
Citations per field
00.5×2.8×
A. Larry Arsenault · 1×
Citations per year

Countries citing papers authored by Markus Neumann

Since Specialization
Citations

This map shows the geographic impact of Markus Neumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Neumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Neumann more than expected).

Fields of papers citing papers by Markus Neumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Neumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Neumann. The network helps show where Markus Neumann may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Neumann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Neumann Line = papers co-authored together Markus Neumann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008269
2 2008203
3 1998196
4 1992118
5 1999113
6 1995106
7 199795
8 201079
9 199175
10 201668
11 200768
12 199759
13 200658
14 199958
15 201052
16 199251
17 199446
18 201044
19 202143
20 200936

About Markus Neumann

Markus Neumann is a scholar working on Molecular Biology, Infectious Diseases, Virology, Biomedical Engineering and Epidemiology, having authored 48 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), Bone Tissue Engineering Materials (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), HIV/AIDS drug development and treatment (5 papers), SARS-CoV-2 detection and testing (4 papers), Calcium Carbonate Crystallization and Inhibition (4 papers), Microbial Metabolic Engineering and Bioproduction (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Virology (440 citations), Microbiology (138 citations), Biomaterials (286 citations), Nephrology (143 citations) and Infectious Diseases (311 citations). Markus Neumann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Matthias Epple, Volker Erfle, George N. Pavlakis, Ruth Brack‐Werner, A. Kleinschmidt, Christian Mayer, Diane Proudfoot, H. Llewelyn Roderick, Martin D. Bootman and Géraldine McCarthy. Their work appears in journals such as Viruses, Scientific Reports, European Journal of Inorganic Chemistry, AIDS and BMC Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact